Tech Company Financing Transactions
Akita Biosciences Funding Round
Flu Lab participated in a capital raise for Akita Biosciences. The round was announced on 4/29/2025.
Transaction Overview
Company Name
Announced On
4/29/2025
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The funding will support a prospective pilot study of Profi Nasal Spray in collaboration with the nation's largest public healthcare system, NYC Health + Hospitals. The study will enroll healthcare workers and evaluate the feasibility of daily use, user adherence, and safety over an eight-week period.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Boston, MA Undisclosed
USA
Boston, MA Undisclosed
USA
Phone
Website
Email Address
Overview
Our vision is to redefine health by unlocking the power of the nose. Through innovative nasal sprays, we strengthen the body's natural defenses, optimize delivery, and help people stay ahead of airborne threats--empowering safer, healthier lives.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alex Revelos
Co-Founder
Nitin Joshi
Co-Founder
Jeffrey Karp
Co-Founder
Christopher Lee
Browse more venture capital transactions:
Prev: 4/29/2025: Dex Talent venture capital transaction
Next: 4/29/2025: Hoofprint Biome venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs